81 FR 62150 - National Institute of Allergy and Infectious Diseases Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 174 (September 8, 2016)

Page Range		62150-62150
FR Document		2016-21616

Federal Register, Volume 81 Issue 174 (Thursday, September 8, 2016)

[Federal Register Volume 81, Number 174 (Thursday, September 8, 2016)]
[Notices]
[Page 62150]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-21616]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Peer Review Meeting.
    Date: October 5, 2016.
    Time: 10:30 a.m. to 5:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 4H200A/B, 5601 Fishers 
Lane, Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Maryam Feili-Hariri, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institutes of Health/NIAID, 5601 Fishers Lane, 
Rockville, MD 20852, 240-669-5026, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: September 2, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-21616 Filed 9-7-16; 8:45 am]
 BILLING CODE 4140-01-P

62150 Federal Register / Vol. 81, No. 174 / Thursday, September 8, 2016 / Notices

Food Safety Modernization Act (FSMA Dated: September 2, 2016. Place: National Institute on Aging,
or the Act), which relate to the functions Natasha M. Copeland, Gateway Building, 7201 Wisconsin Avenue,
of the Food and Drug Administration. Suite 2W200, Bethesda, MD 20892
Program Analyst, Office of Federal Advisory
This authority may be redelegated. (Telephone Conference Call).
Committee Policy.
Contact Person: Jeannette L. Johnson,
This authority will be exercised in [FR Doc. 2016–21616 Filed 9–7–16; 8:45 am] Ph.D., National Institute on Aging, National
accordance with the Department of BILLING CODE 4140–01–P Institutes of Health, 7201 Wisconsin Avenue,
Health and Human Services applicable Suite 2W200, Bethesda, MD 20892, 301–402–
policies, procedures, guideline, and 7705, JohnsonJ9@NIA.NIH.GOV.
regulations. DEPARTMENT OF HEALTH AND (Catalogue of Federal Domestic Assistance
I hereby ratify and affirm any actions HUMAN SERVICES Program Nos. 93.866, Aging Research,
taken the Commissioner, or the National Institutes of Health, HHS)
Commissioner’s subordinates, that National Institutes of Health Dated: September 1, 2016.
involved the exercise of the authority
Center for Scientific Review; Amended Melanie J. Gray,
delegated herein prior to the effective
date of this delegation. Notice of Meeting Program Analyst, Office of Federal Advisory
This delegation is effective upon date Committee Policy.
Notice is hereby given of a change in [FR Doc. 2016–21516 Filed 9–7–16; 8:45 am]
of signature. the meeting of the Cellular Signaling BILLING CODE 4140–01–P
Sylvia M. Burwell, and Regulatory Systems Study Section,
Secretary. September 29, 2016, 08:00 a.m. to
[FR Doc. 2016–21504 Filed 9–7–16; 8:45 am] September 29, 2017, 06:00 p.m., DEPARTMENT OF HEALTH AND
BILLING CODE P
Residence Inn Bethesda, 7335 HUMAN SERVICES
Wisconsin Avenue, Bethesda, MD 20814
which was published in the Federal National Institutes of Health
DEPARTMENT OF HEALTH AND Register on August 31, 2016, 81 FR PG
HUMAN SERVICES 60010. Announcement of Requirements and
The end date is September 29, 2016 Registration for ‘‘Antimicrobial
National Institutes of Health instead of September 29, 2017. The Resistance Rapid, Point-of-Need
meeting location remains the same. The Diagnostic Test’’ Challenge
National Institute of Allergy and meeting is closed to the public.
Infectious Diseases Notice of Closed Authority: 15 U.S.C. 3719.
Dated: September 1, 2016.
Meeting
David Clary, SUMMARY: Through the ‘‘Antimicrobial
Pursuant to section 10(d) of the Program Analyst, Office of Federal Advisory Resistance Rapid, Point-of-Need
Federal Advisory Committee Act, as Committee Policy. Diagnostic Test’’ Challenge (the
amended (5 U.S.C. App.), notice is [FR Doc. 2016–21514 Filed 9–7–16; 8:45 am] ‘‘Challenge’’), the National Institutes of
hereby given of the following meeting. BILLING CODE 4140–01–P
Health (NIH) and the Biomedical
The meeting will be closed to the Advanced Research and Development
public in accordance with the Authority (BARDA) of the Office of the
provisions set forth in sections DEPARTMENT OF HEALTH AND Assistant Secretary for Preparedness
552b(c)(4) and 552b(c)(6), title 5 U.S.C., HUMAN SERVICES and Response (ASPR) are searching for
as amended. The contract proposals and novel and innovative in vitro diagnostic
the discussions could disclose National Institutes of Health tests that would rapidly inform clinical
confidential trade secrets or commercial treatment decisions and be of potential
property such as patentable material, National Institute on Aging Notice of significant clinical and public health
and personal information concerning Closed Meeting utility to combat the development and
individuals associated with the contract Pursuant to section 10(d) of the spread of antibiotic resistant bacteria.
proposals, the disclosure of which Federal Advisory Committee Act, as Tests of interest will provide novel,
would constitute a clearly unwarranted amended (5 U.S.C. App.), notice is innovative solutions for use in inpatient
invasion of personal privacy. hereby given of the following meeting. and/or outpatient settings. The goal of
Name of Committee: National Institute of The meeting will be closed to the the challenge is to identify a diagnostic
Allergy and Infectious Diseases Special public in accordance with the test that when utilized would lead to
Emphasis Panel; NIAID Peer Review Meeting. provisions set forth in sections more rapid clinical decision making
Date: October 5, 2016. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., such that antibiotic use and/or
Time: 10:30 a.m. to 5:30 p.m. outcomes of patients infected with
Agenda: To review and evaluate contract
as amended. The grant applications and
the discussions could disclose resistant pathogens are fundamentally
proposals.
Place: National Institutes of Health, confidential trade secrets or commercial improved compared to current standard
4H200A/B, 5601 Fishers Lane, Rockville, MD property such as patentable material, of care, and/or reduce transmission of
20892 (Telephone Conference Call). and personal information concerning resistant pathogens such that population
Contact Person: Maryam Feili-Hariri, individuals associated with the grant infection rates significantly decrease.
Ph.D., Scientific Review Officer, Scientific applications, the disclosure of which The Challenge competition seeks to
Review Program, Division of Extramural incentivize a broad range of scientists,
would constitute a clearly unwarranted
Activities, National Institutes of Health/ engineers, and innovators to develop
mstockstill on DSK3G9T082PROD with NOTICES

NIAID, 5601 Fishers Lane, Rockville, MD invasion of personal privacy.
20852, 240–669–5026, haririmf@
diagnostic tests that would enable
Name of Committee: National Institute on
niaid.nih.gov. Aging Special Emphasis Panel; Training
health care providers to make more
(Catalogue of Federal Domestic Assistance Grants. informed decisions on appropriate
Program Nos. 93.855, Allergy, Immunology, Date: October 18, 2016. antibiotic use and infection prevention.
and Transplantation Research; 93.856, Time: 2:00 p.m. to 6:00 p.m. This Challenge, structured in three
Microbiology and Infectious Diseases Agenda: To review and evaluate grant steps, will complement existing BARDA
Research, National Institutes of Health, HHS) applications. and NIH research portfolios by reaching

VerDate Sep<11>2014 19:34 Sep 07, 2016 Jkt 238001 PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 E:\FR\FM\08SEN1.SGM 08SEN1

Document Created: 2018-02-09 13:13:09
Document Modified: 2018-02-09 13:13:09

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		October 5, 2016.
FR Citation		81 FR 62150

81 FR 62150 - National Institute of Allergy and Infectious Diseases Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 174 (September 8, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health